Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Neurodegeneration: Problems at the nuclear pore.

Fox BW, Tibbetts RS.

Nature. 2015 Sep 3;525(7567):36-7. doi: 10.1038/nature15208. Epub 2015 Aug 26. No abstract available.

PMID:
26308896
2.

Pheromone sensing regulates Caenorhabditis elegans lifespan and stress resistance via the deacetylase SIR-2.1.

Ludewig AH, Izrayelit Y, Park D, Malik RU, Zimmermann A, Mahanti P, Fox BW, Bethke A, Doering F, Riddle DL, Schroeder FC.

Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5522-7. doi: 10.1073/pnas.1214467110. Epub 2013 Mar 18.

3.

A shortcut to identifying small molecule signals that regulate behavior and development in Caenorhabditis elegans.

Pungaliya C, Srinivasan J, Fox BW, Malik RU, Ludewig AH, Sternberg PW, Schroeder FC.

Proc Natl Acad Sci U S A. 2009 May 12;106(19):7708-13. doi: 10.1073/pnas.0811918106. Epub 2009 Apr 3.

4.

Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.

Newell DR, Burtles SS, Fox BW, Jodrell DI, Connors TA.

Br J Cancer. 1999 Nov;81(5):760-8.

5.

The history of radium in medicine in Manchester.

Fox BW.

Clin Oncol (R Coll Radiol). 1998;10(2):115-24. No abstract available.

PMID:
9610901
6.

The interaction with tubulin of a series of stilbenes based on combretastatin A-4.

Woods JA, Hadfield JA, Pettit GR, Fox BW, McGown AT.

Br J Cancer. 1995 Apr;71(4):705-11.

8.

Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.

Prendiville J, McGown AT, Gescher A, Dickson AJ, Courage C, Pettit GR, Crowther D, Fox BW.

Br J Cancer. 1994 Oct;70(4):573-8.

9.

Structure-activity studies on 2-aryl-4H-3,1-benzoxazin-4-ones.

Hadfield JA, Pavlidis VH, McGown AT, Whitworth C, Perry PJ, Fox BW.

Anticancer Drugs. 1994 Oct;5(5):533-8.

PMID:
7858285
10.

Correlation of drug resistance-associated parameters in ovarian tumor biopsies.

McGown AT, Murphy D, Swindell R, Crowther D, Fox BW.

Int J Gynecol Cancer. 1994 Jul;4(4):241-249.

PMID:
11578413
11.
12.

Bioactivity and molecular modelling of diphenylsulfides and diphenylselenides.

Woods JA, Hadfield JA, McGown AT, Fox BW.

Bioorg Med Chem. 1993 Nov;1(5):333-40.

PMID:
8081863
13.

A phase I study of intravenous bryostatin 1 in patients with advanced cancer.

Prendiville J, Crowther D, Thatcher N, Woll PJ, Fox BW, McGown A, Testa N, Stern P, McDermott R, Potter M, et al.

Br J Cancer. 1993 Aug;68(2):418-24.

14.

The suitability of carboplatin solutions for 14-day continuous infusion by ambulatory pump: an HPLC-dynamic FAB study.

Hadfield JA, McGown AT, Dawson MJ, Thatcher N, Fox BW.

J Pharm Biomed Anal. 1993 Aug;11(8):723-7.

PMID:
8257737
16.

Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patients.

Stewart JP, McGown AT, Prendiville J, Pettit GR, Fox BW, Arrand JR.

Cancer Chemother Pharmacol. 1993;33(1):89-91.

PMID:
8269596
17.

A comparative binding of platinum anti-tumour compounds to plasma proteins in the rat (in vivo) and mouse (in vitro).

Perera A, Jackson H, Sharma HL, McAuliffe CA, Fox BW.

Chem Biol Interact. 1992 Dec;85(2-3):199-213.

PMID:
1493609
18.

Current results with rhizoxin: the evaluation of a clinical and a basic scientist.

Fox BW.

Ann Oncol. 1992 Nov;3(9):707-9. No abstract available.

PMID:
1450059
19.
21.

Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump.

Hrubisko M, Mc Gown AT, Prendiville JA, Radford JA, Thatcher N, Fox BW.

Cancer Chemother Pharmacol. 1992;29(3):252-5.

PMID:
1733559
23.

Metallothionein levels in ovarian tumours before and after chemotherapy.

Murphy D, McGown AT, Crowther D, Mander A, Fox BW.

Br J Cancer. 1991 May;63(5):711-4.

25.

DNA interstrand crosslinking and sequence selectivity of dimethanesulphonates.

Ponti M, Souhami RL, Fox BW, Hartley JA.

Br J Cancer. 1991 May;63(5):743-7.

26.
27.

Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapy.

McGown AT, Murphy D, Crowther D, Fox BW.

Cancer Chemother Pharmacol. 1991;27(5):413-5.

PMID:
1999005
28.

Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines.

McGown AT, Fox BW.

Cancer Chemother Pharmacol. 1990;26(1):79-81.

PMID:
2322992
29.

Interaction of the novel agent amphethinile with tubulin.

McGown AT, Fox BW.

Br J Cancer. 1989 Jun;59(6):865-8.

30.

The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo.

Lind MJ, McGown AT, Hadfield JA, Thatcher N, Crowther D, Fox BW.

Biochem Pharmacol. 1989 Jun 1;38(11):1835-40.

PMID:
2735940
32.
33.
34.

A phase I and pharmacokinetic study of amphethinile.

Smith DB, Ewen C, Mackintosh J, Fox BW, Thatcher N, Scarffe JH, Vezin R, Crowther D.

Br J Cancer. 1988 Jun;57(6):623-7.

35.

Pre-clinical studies of a novel anti-mitotic agent, amphethinile.

McGown AT, Ewen C, Smith DB, Fox BW.

Br J Cancer. 1988 Feb;57(2):157-9.

36.

An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin.

Ewen C, Perera A, Hendry JH, McAuliffe CA, Sharma H, Fox BW.

Cancer Chemother Pharmacol. 1988;22(3):241-5.

PMID:
3044632
37.
38.

Phase I clinical trial of methylene dimethane sulfonate.

Smith DB, Fox BW, Thatcher N, Steward WP, Scarffe JH, Wagstaff J, Vezin R, Crowther D.

Cancer Treat Rep. 1987 Sep;71(9):817-20.

PMID:
3621213
39.
40.
41.
42.

Do today's dental schools teach assembly-line dentistry?

Fox BW.

CAL. 1984 May;47(11):13-5. No abstract available.

PMID:
6586261
44.
45.

Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.

Poppitt DG, McGown AT, Fox BW.

Cancer Chemother Pharmacol. 1984;13(1):43-6.

PMID:
6733841
46.

Dental school circa 1920.

Fox BW.

CAL. 1983 Dec;47(6):9-11, 21. No abstract available.

PMID:
6362800
47.

Turn of the century dentistry.

Fox BW.

CAL. 1983 Aug;47(2):18-9, 21-4. No abstract available.

PMID:
6349751
49.

Supplemental Content

Support Center